Hadassah Medical CenterHadassah Medical Center
   Home    About    Treatment In Israel    Contact 
Home > Physicians, Researchers

Dr. Leon Gilead, MD, PhD

Updated January 2010

 

 

Mohs Surgeon, Head of Mohs Surgery Clinic

Department of Dermatology

Hadassah University Hospital

Jerusalem, Israel 91120

Mobile: 972-500-7874309

E-mail: leong@cc.huji.ac.il

 

 

Born: January 19, 1960, Haifa, Israel.

Marital status: Married + four children.

 

Academic:

 

1982 – 1985: B.Sc.med in Life sciences, With excellence. "Hebrew University and Hadassah's Medical School", Jerusalem, Israel.   

      

1985 – 1989:  Ph.D. in biochemistry. "Hebrew University and Hadassah's Medical School", Jerusalem, Israel.

  

1987 – 1990: M.D.. "Hebrew University and Hadassah's Medical School",   Jerusalem, Israel.  

 

1990 – 1991: Internship. "Hadassah University Medical Center", Jerusalem, Israel.

 

1992 – 1996: Resident in Dermatology. "Hadassah University Medical Center", Jerusalem, Israel.

 

1996: Plastic & Derm Surgery Clerkship

 

1996: Board Certified - Dermatologist

 

1993 – 1996: Editor of 'Al-Hadofek' (="on the pulse") The Hebrew University and Hadassah's Medical School alumni journal.

 

1994 – 1998: Instructor in Dermatology, Hebrew University Medical School, Jerusalem, Israel

 

1996: Senior physician, Department of Dermatology, Hadassah Medical Center

 

1998: Manager of the Hard to Heal Wound Clinic and Derm-surgery

 

2002: Medical Director, Israel Hansen's Disease Center, Ministry of Health and Hadassah

 

2003: Head of the Inpatient Hard to Heal Wound Team of the Hadassah Medical Center

 

2003 – 2006: Physician in "Lase-Ohr" medical & aesthetic laser treatment center

 

2004: Attended "Fundamentals of Mohs Surgery" training course of the American Society of MOHS Surgery

 

2005: Mohs Surgeon, Head of Mohs Surgery Clinic

 

Awards 

 

1984: "Hebrew University and Hadassah Medical School - department of Human Anatomy" prize for best student in anatomy.

 

1985: Dean's list of excellent students.

 

1994: Scholarship award under the International Scholarship Program of the18th World Congress of Dermatology, The American academy of dermatology, 1995.

 

1996: Louis and Ana Rosof Faculty Price for Excellence in clinical work

 

Fellowships:

 

1985 – 1990: Full Tuition fees by the Hebrew university for students in the combined program of studies for MD/Ph.D.

 

1987 – 1990: Foulkes Foundation Fellowship.

 

Memberships:

 

*      1993: Israel Society for Dermatology and Venereology

*      1993: Israel Society of Investigative Dermatology

*       1994: Israel Society for Dermatologic Surgery

*      1997: American Academy of Dermatology

*      2004: American Society of MOHS surgery

 

List of Publications

 

1. Histamine and chondroitin sulfate E proteoglycan released by cultured human colonic mucosa: Indication for possible presence of E mast cells. Eliakim, R., Gilead L., Ligumsky M., Okon E., Rachmilewitz D. & E. Razin. Proc.Natl.Acad.Sci.USA, 83, 461-464, 1986.

 

2. Human gastric mucosal mast cells are chondroitin sulfate E containing mast cells.    Gilead L., Livni N., Eliakim R., Ligumsky M., Fich A., Okon E., Rachmilewitz D. & E. Razin. Immunology, 62, 23-28, 1987.

 

3. Cultured human bone marrow-derived mast cells, their similarities to cultured murine E-mast cells. Gilead L., Rahamim E., Ziv I., Or R. & E. Razin. Immunology, 63, 669-675, 1988.

 

4. Human interleukin 3: one of the human mast cell growth factors. Gilead L. & E. Razin. FASEB J. Abst., p.A687, 1988.

 

5. Synthesis of chondroitin sulfate D and heparin proteoglycans in murine lymph node derived mast cells, the dependency on fibroblasts. Davidson S., Gilead L., Amira M., Ginsburg H. & E. Razin.  J.Biol.Chem., 265, 12324-12330, 1990.

 

6. Fibroblast induced heparin synthesis in chondroitin sulfate E containing, human bone marrow derived, mast cells. Gilead L., Bibi O. & E. Razin. Blood, 76, 1188-1195, 1990.

 

7. A look at gray hair. Vardy DA, Marcus B-S, Gilead L, Klapholz L, Lichtenstein DA, Rashkovsky I, Klaus SN,. J.Geriat.Dermatol., 1993, 1(1):22-27.

 

8. Mammary calcifications in Weber-Christian disease. Leibovici V, Gilead L, Gimmon Z, Lax E, 1994, Eur.J.Radiol., 18(1):70-1.

 

9. Treatment of vulvar lichen sclerosus in the elderly - an update. Elhalal U., Gilead L., Vardy D.A., Ben-Shahar I., Anteby S.O., Schenkar J.G., 1995, Obstet. Gynecol. Surv., 50(2):155-62.

 

10. Tefillin Dermatitis (A phylacteric phenomenon).  Gilead L.,  Vardy D.A.,  Schamroth J., 1995, J.Am.Acad. Dermatol., 32:812-3.

 

11. Acro-angiodermatitis: review of the literature and Report of a case. Rashkovsky  I.,  Gilead L.,  Shamroth J.,  Leibovici V., ACTA Dermatol.Venereol., 1995, 75:475..

 

12. Immunosuppression-induced Porokeratosis of Mibelli: complete regression of lesions upon cessation of immunosuppressive therapy. Gilead L., Guberman D., Zlotogorsky A., Vardy D.A., Klaus S.N., J.Eur.Acad.Dermatol.Venereol., 1995, 5:170-172.

 

13. Chronic radiodermatitis following cardiac catheterization.  Lichtenstein D.A., Klapholz L., Vardy D., Leidhter I., Mosseri M., Klaus S.N., Gilead L.T., Arch Dermatol, 1996; 132:663-667.

 

14. Fever, Convulsions and Coma in Scleromyxedema: a “dermato-neuro syndrome”. River Y., Levi I., Gilead L., Orbach H.,  Almog Y., Neurology, 1996, 46:1778-9.

 

15. Familial pityriasis rotunda [letter] Guberman D., Lichtenstein D.A., Gilead L., Vardy D.A., Klaus S.N., Acta.Derm.Venereol. 1997 Mar; 77(2): 162.

 

16. Porokeratosis of Mibelli. Overview and review of the literature. Schamroth J.M., Zlotogorski A., Gilead L., Acta.Derm.Venereol. 1997 May; 77(3): 207-13.

 

17. Salicilism following topical aplication of 20% salicilic acid for psoriasis. Jabarah A., Gilead L., Zlotogorski A., J.Eur.Acad.Dermatol.Venereol., 1997, 8:41-2.

 

18. Terra firma forme dermatosis. Raveh T, Gilead LT, Wexler MR, Ann Plast Surg 1997 Nov;39(5):542-545

 

19. Chronic unilateral leg inflammation in a young man. Guberman D, Reinus C, Gilead L, Goldenhersh MA, Arch Dermatol 1998 Jun;134(6):743

 

20. South American cutaneous leishmaniasis: report of ten cases in Israeli travelers. Zlotogorski A, Gilead L, Jonas F, Horev L, Klaus SN, Eur Acad Dermatol Venereol  1998 Jul;11(1):32-36

 

21. Skin calcinosis following allogenic bone marrow transplantation in an acute lymphoblastic leukaemia patient. Guberman D, Gilead LT, Nagler A . Acta Derm Venereol. 1999 Jul;79(4):324-5.

 

22. Maggot therapy for the treatment of intractable wounds. Mumcuoglu KY, Ingber A, Gilead L, Stessman J, Friedmann R, Schulman H, Bichucher H, Ioffe-Uspensky I, Miller J, Galun R, Raz I, Int J Dermatol 1999 Aug;38(8):623-7.

 

23. Bullous Erysipellas - A retrospective study of 26 cases, Guberman D., Gilead L., Zlotogorski A., Schamroth J., J Am Acad Dermatol. 1999 Nov;41(5 Pt 1):733-7.

 

24. Maggot therapy for the treatment of diabetic foot ulcers. Mumcuoglu KY, Ingber A, Gilead L, Stessman J, Friedmann R, Schulman H, Bichucher H, Ioffe-Uspensky I, Miller J, Galun R, Raz I, Diabetes Care 1998 Nov;21(11):2030-1

 

25. Maggot therapy for the treatment of intractable wounds. Mumcuoglu KY, Ingber A, Gilead L, Stessman J, Friedmann R, Schulman H, Bichucher H, Ioffe-Uspensky I, Miller J, Galun R, Raz I. Int J Dermatol. 1999 Aug; 38(8): 623-7.

 

25. Maggot debridement therapy in outpatients. Sherman RA, Sherman J, Gilead L, Lipo M, Mumcuoglu KY. Arch Phys Med Rehabil. 2001 Sep; 82(9:1226-9.

 

26. Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B. Vardy D, Barenholz Y, Naftoliev N, Klaus S, Gilead L, Frankenburg S. Trans R Soc Trop Med Hyg. 2001 Mar-Apr; 95(2): 184-6.

 

27. Mediterranean spotted fever in Israel: a tick-borne disease. Mumcuoglu KY, Keysary A, Gilead L. Isr Med Assoc J. 2002 Jan; 4(1): 44-9.

 

28. Treatment of cutaneous leishmaniasis--an update] Vardy DA, Gilead L, Frankenburg S. Harefuah. 2002 Jan; 141(1): 70-5, 125, 124.

 

29. Fatal hemophagocytic syndrome in a patient with panniculitis-like T-cell lymphoma and no clinical evidence of disease. Goldschmidt N, Amir G, Krieger M, Gilead L, Paltiel O., Leuk Lymphoma. 2003 Oct; 44(10): 1803-6.

 

30. Diagnostic performance and retention of acquired skills after dermatology elective. Enk CD, Gilead L, Smolovich I, Cohen R. Int J Dermatol. 2003 Oct; 42(10): 812-5.

 

31. Intralesional therapy of oral leishmaniasis. Czerniski R, Gilead L, Abedelmajeed N, Markitziu A. Int J Dermatol. 2003 Sep; 42(9): 752-4.

 

32. A nonsense mutation in the desmoglein 1 gene underlies striate keratoderma. Kljuic A, Gilead L, Martinez-Mir A, Frank J, Christiano AM, Zlotogorski A.  Exp Dermatol. 2003 Aug; 12(4): 523-7.

 

33. Combined therapy for pyoderma gangrenosum.  Rozin AP, Balbir-Gurman A, Gilead L, Slodownik D., Ann Rheum Dis. 2004 Jul;63(7):888-9

 

34. Plantar ulcers and eyebrow-hair paucity. Elinav H, Palladas L, Applbaum YH, Gilead L, Moses AE, Cohen-Poradosu R. Clin Infect Dis. 2006 Mar 1;42(5):684-5, 722-4.

 

35. Recommendations for the treatment of scabies infestations in Israel. Mumcuoglu KY, Gilead LT, Isr Med Assoc J. 2006 Mar;8(3):196-9.

 

36. The use of hybrid radiofrequency device for the treatment of rhytides and lax skin. Friedman DJ, Gilead LT, Dermatol Surg. 2007 May;33(5):543-51.

 

37. Treatment of scabies infestations. Mumcuoglu KY, Gilead L. Parasite. 2008 Sep;15(3):248-51.

 

38. Physicians' knowledge in Israel on the biology and control of head lice] Mumcuoglu KY, Mumcuoglu M, Danilevich M, Gilead L., Harefuah. 2008 Oct;147(10):754-7, 840. Hebrew.

 

                                                                                        




Dr. Leon Gilead


            
     
 


         Powered by